In the BioHarmony Drug Report Database

"Preview" Icon

Nefazodone

Serzone (nefazodone) is a small molecule pharmaceutical. Nefazodone was first approved as Serzone on 1994-12-22. It is used to treat depressive disorder and post-traumatic stress disorders in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter, sodium-dependent serotonin transporter, and 5-hydroxytryptamine receptor 2A. In addition, it is known to target cytochrome P450 3A4.

 

Trade Name

 

Serzone
 

Common Name

 

nefazodone
 

ChEMBL ID

 

CHEMBL623
 

Indication

 

depressive disorder, post-traumatic stress disorders
 

Drug Class

 

Image (chem structure or protein)

Nefazodone structure rendering